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Available online 22 December 2016Isobutyryl-CoA Dehydrogenase Deﬁciency (IBDD) is an inherited disorder of valinemetabolism caused bymuta-
tions in ACAD8. Most reported patients have been diagnosed through newborn screening programmes due to el-
evated C4-carnitine levels and appear clinically asymptomatic. One reported non-screened patient had dilated
cardiomyopathy and anaemia at the age of two years. We report a 13 month old girl diagnosed with IBDD
after developing hypoglycaemic encephalopathy (blood glucose 1.9 mmol/l) during an episode of rotavirus-in-
duced gastroenteritis. Metabolic investigations demonstrated an appropriate ketotic response (free fatty acids
2594 μmol/l, 3-hydroxybutyrate 3415 μmol/l), mildly elevated plasma lactate (3.4 mmol/l), increased C4-carni-
tine on blood spot and plasma acylcarnitine analysis and other metabolic abnormalities secondary to ketosis.
After recovery, C4-carnitine remained increased and isobutyrylglycine was detected on urine organic acid anal-
ysis. Free carnitine was normal in all acylcarnitine samples. IBDD was conﬁrmed by ﬁnding a homozygous
c.845C N T substitution in ACAD8. The patientwas given, but has not used, a glucose polymer emergency regimen
and after ten years' follow-up has had no further episodes of hypoglycaemia nor has she developed cardiomyop-
athy or anaemia. Psychomotor development has been normal to date. Thoughwe suspect IBDDdidnot contribute
to hypoglycaemia in this patient, patients should be followed-up carefully and glucose polymer emergency reg-
imens may be indicated if recurrent episodes of hypoglycaemia occur.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Ketotic hypoglycaemia
ACAD8
Newborn screening1. Introduction
Isobutyryl-CoA Dehydrogenase (IBD) is a mitochondrial enzyme
which catalyses the conversion of isobutyryl-CoA to methylacrylyl-
CoA in the third step of valine catabolism [1]. It is encoded by ACAD8 lo-
cated on chromosome 11q25. Patients with inherited IBD deﬁciency
(IBDD; McKusick 611283) have mostly been diagnosed through new-
born screening programmes due to elevated C4-carnitine levels [2–5].
C4-carnitine may represent butyrylcarnitine (as seen in short chain
acyl-CoA dehydrogenase deﬁciency, SCADD) or isobutyrylcarnitine
from IBDD. Algorithms have been developed to distinguish these two
conditions in newborns with elevated C4-carnitine levels [6]. Patients
with IBDDdiagnosed in thisway have appeared clinically asymptomatic
though a few patients have shown speech delay. It is uncertain what
treatment, if any, is required following diagnosis. One reported patient
who was not diagnosed from a newborn screening programme had's Hospital, Steelhouse Lane,
. This is an open access article underanaemia and dilated cardiomyopathy, thought to have been caused by
secondary carnitine deﬁciency, at the age of two years [7]. Some groups
have suggested the use of carnitine supplementation and dietary pro-
tein restriction for conﬁrmed cases, but the lack of signiﬁcant symptoms
developing in prospectively followed patients diagnosed from newborn
screening programmes, as well as the dearth of clinically presenting
cases reported in the literature, has meant that these practices are not
widely followed, most centres advocating careful follow-up only [8].
To our knowledge no patient with IBDD has previously been reported
to have developed hypoglycaemia. Herewe present a case of IBDD diag-
nosed in theUnitedKingdom,where C4-carnitine is not part of the new-
born screening programme,who presentedwith ketotic hypoglycaemic
encephalopathy during an intercurrent gastroenteritis illness.
2. Methods
2.1. Ethics
This article does not contain any experimental studies with human
or animal subjects performedby any of the authors and therefore ethicalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tion was obtained from the family of the child included in the report.
2.2. ACAD8/ACADS sequencing
PCR ampliﬁcation of all ACAD8 exons and part of the ﬂanking introns
was performed as described elsewhere [9]. PCR fragments were se-
quenced in both directions on a 3100-Avant genetic analyzer using
BigDye® Terminator v1.1 Cycle Sequencing kit, and using
NM_014384.2 as a reference sequence
Rare variants were identiﬁed based on a comparison against allelic
frequencies from dbSNPv142, and Exome Aggregation Consortium
(ExAC).
3. Results
3.1. Case report
The patient was a 13-month-old female who was born at term by
normal spontaneous vaginal delivery to a mother of Pakistani origin.
The patient's maternal great-grandmother and paternal grandfather
were ﬁrst cousins. There had been no clinical or developmental con-
cerns with the child over the ﬁrst year of life. 48 h prior to admission
she had received vaccination against measles, mumps and rubella and
developed low-grade post-immunisation pyrexia. The next day she de-
veloped non-bilious vomiting and diarrhoea which continued for more
than 24 h. At the same time, her appetite was poor and she drankwater
only. During the four hours prior to admission, the child was drowsy
and difﬁcult to rouse and she was brought to the hospital emergency
department where initial investigations revealed a moderate metabolic
acidosis (pH 7.29, base excess−8.5 mmol/l) with hypoglycaemic en-
cephalopathy (blood glucose 1.9 mmol/l). She had rapid clinical im-
provement with intravenous dextrose administration and faecal
analysis subsequently conﬁrmed that rotavirus caused gastroenteritis.
No further hypoglycaemia developed after reintroduction of oral feed-
ing and she was discharged home three days later.
Metabolic investigations collected at the time of hypoglycaemia
demonstrated an appropriate ketotic response (free fatty acids
2594 μmol/l, 3-hydroxybutyrate 3415 μmol/l) and mildly elevated lac-
tate (3.4 mmol/l [reference range 0.6–2.6]). Blood spot and plasma
acylcarnitine analysis revealed an unusually prominent peak of C4-car-
nitine aswell as increases in a number of acylcarnitines secondary to ke-
tosis. Free carnitine was normal (25 μmol/l [reference range 15–53])
Organic acids during illness demonstrated features of ketosis with
grossly elevated 3-hydroxybutyrate and acetoacetate as well as a dicar-
boxylic aciduria.
After recovery, C4-carnitine remained increased and
isobutyrylglycine was detected on urine organic acid analysis. Fatty
acid oxidation ﬂux studies demonstrated normal oxidation of myristate
and oleate in cultured ﬁbroblasts though there was evidence for a par-
tial defect in short chain fatty acid oxidation (butyrate release
0.93 pmol CO2/min/mg protein, normal controls 2.4–19.4).
3.2. ACAD8 and ACADS sequencing
DNA sequencing of ACAD8 identiﬁed a novel homozygous missense
c.845C N T substitution. This is predicted to cause a single amino acid
substitution of serine at position 282 to phenylalanine (p.Ser282Phe).
The serine-282 residue is highly conserved across vertebrate species
supporting the pathogenicity of this variant. This variant is reported
only 6 times in ExAC and only in individuals of South Asian origin
with no homozygotes reported, giving an allele frequency of
0.0003634 in this ethnicity. It is listed as rs770663870 in dbSNP
(http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=rs770663870). The
variant is predicted to be deleterious in silico by both Polyphen andSIFT. Parental consent to DNA testing was not provided to conﬁrm ho-
mozygosity. DNA sequencing of ACADS did not reveal any mutations.
3.3. Clinical course
The child was providedwith a 15% glucose polymer emergency reg-
imen once the diagnosis was suspected and this has been increased ap-
propriately with age. No change was made to the child's normal daily
diet.
The child has been followed up regularly for the ten years since diag-
nosis and has remained well. There have been no further episodes of
hypoglycaemia and in fact the emergency regimen has never actually
been required. The child's free carnitine has measured between 25
and 31 μmol/l on follow-up and carnitine supplementation has not
been deemed necessary. Serial full blood count estimations have
shown no sign of anaemia (Haemoglobin 127 g/l [reference range
120–160] at 11 years of age). Serial echocardiography has shown no ev-
idence of cardiomyopathy over the ten years of follow-up with a short-
ening fraction in M-mode of 32% at 11 years of age. There have been no
concerns about the child's development and she has remained in main-
stream education throughout.
4. Discussion
Persistent elevations of C4-carnitine may suggest disturbance in
short chain fatty acid oxidation (e.g. SCADD) leading to butyrylcarnitine
accumulation or a disturbance in valine metabolism (e.g. IBDD) leading
to isobutyrylcarnitine accumulation. The overwhelming majority of pa-
tients with IBDD detected from newborn screening programmes have
been clinically asymptomatic and it remains uncertain how signiﬁcant
SCADD is as a cause of hypoglycaemia in childhood, though disturbance
in longer chain fatty acid oxidation is certainly associated with
hypoglycaemia. This child presented with ketotic hypoglycaemic en-
cephalopathy during an episode of gastroenteritis andmetabolic abnor-
malities present at the time of hypoglycaemiawere investigated further
leading to a diagnosis of IBDD. It remains uncertain whether IBDD con-
tributed to hypoglycaemia in this patient. Disturbed valine catabolism
would not be expected to be associated with hypoglycaemia. IBD is,
however, one member of the acyl-CoA dehydrogenase family and
there is signiﬁcant sequence and structural similarity across members
of this family [9]. Indeed it is recognised that some acyl-CoA dehydroge-
nases are able to catalyse the metabolism of substrates for other mem-
bers of the family, with reduced afﬁnity [1,10]. For example medium
chain acyl-CoA dehydrogenase is known to have detectable but low ac-
tivity towards longer chain acyl-CoAmolecules. IBD and SBCAD are also
known to have some cross-reactivitywith their respective substrates [1,
11]. It is therefore tempting to suggest that IBD and SCAD may have
some cross-reactivity but cross-reactivity between an enzyme involved
in amino acid catabolism and an enzyme involved in fatty acid oxidation
has not been described. The structure of IBDhas been elegantly elucidat-
ed andwhilst the structure sharesmany similarities to that of SCAD, the
substrate binding site is wider to allow stable binding of molecules with
a 2-methyl group rather than the narrower SCAD substrate binding site
which favours straight-chain molecules [11]. Puriﬁed recombinant
ACAD8 enzyme has been shown to be virtually inactive towards
butyryl-CoA in vitro [9] however ﬁbroblasts from this patient did dem-
onstrate a partial defect in butyrate oxidation and the reason for this
is uncertain.
Hypoglycaemia in IBDD has not been reported in other patients di-
agnosed from newborn screening programmes or otherwise, nor was
it seen as a recurrent phenomenon in this child. Even if there were
some ability of IBD to metabolise short chain fatty acids in vivo one
would expect the normal activity of SCAD to compensate for deﬁciency
of this seen in a patient with IBDD. With this in mind it is relevant to
note that the ﬁrst reported case of IBDD, andmany other cases detected
through newborn screening, have additionally been at least
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could conceivable have a bearing on the likelihood of clinical problems
developing. This was not, however, the case in this child in whom
ACADS sequencing revealed no pathogenic variant. Furthermore
hypoglycaemia is known to complicate the clinical course of infants
with severe rotavirus gastroenteritis even without any underlying in-
born error of metabolism [12]. It is more likely, therefore, that this
child's hypoglycaemia was not primarily caused by IBDD although a
contributing role of this condition in early life cannot be excluded.
Some recently discovered inborn errors of metabolism have been
shown to be associated with clinical symptoms only during infancy
[13] with cases remaining asymptomatic in later life and it is conceiv-
able that such mechanisms may also affect the expression of clinical
symptoms in IBDD. Furthermore, the normal developmental, haemato-
logical and cardiac follow-up of this child suggests that previously re-
ported learning difﬁculties, anaemia and cardiomyopathy are not
necessarily proven associations with IBDD, though this child did not
have systemic carnitine deﬁciency either at presentation or on follow-
up.
5. Conclusions
In conclusion, the clinical signiﬁcance of IBDD is uncertain and it re-
mains a dilemma for clinicians managing children diagnosed through
newborn screening programmes. Very few cases presenting with clini-
cal symptoms are reported in the literature. We present the case of a
child who was diagnosed through investigation for ketotic
hypoglycaemia. In retrospect whilst it is unlikely that IBDD solely
caused the hypoglycaemia in this patient, it is possible that this episode
wasmore pronounced due to IBDD. Given the uncertainty of the natural
history of IBDD, however, we would recommend patients are followed-
up carefully and glucose polymer emergency regimens may be indicat-
ed if recurrent episodes of hypoglycaemia occur.
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